Cipla Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹7,074.48 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.79 per cent from ₹7,589.44 crore. This corresponds to a year-on-year *(YoY) growth of 0.02 per cent.
Operating Profit
Operating Profit stands at ₹979.15 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 48.32 per cent from ₹1,894.75 crore. This corresponds to a year-on-year *(YoY) decline of 50.77 per cent.
PBDT
PBDT stands at ₹1,171.15 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 45.55 per cent from ₹2,150.82 crore. This corresponds to a year-on-year *(YoY) decline of 46.44 per cent.
Profit Before Tax
Profit Before Tax stands at ₹892.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 51.84 per cent from ₹1,853.83 crore. This corresponds to a year-on-year *(YoY) decline of 53.18 per cent.
Net Profit
Net Profit stands at ₹674.25 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 50.18 per cent from ₹1,353.37 crore. This represents a 57.18 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Cipla Ltd News
Cipla Ltd Earnings
- YOY
- QOQ
Cipla Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Cipla Ltd Research Reports
Cipla Ltd Financial Reports
Cipla Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Cipla | 1.50% | 6.59% | 7.45% | -1.06% | -16.29% | -15.46% |
| Divi's Lab. | 1.74% | 2.93% | 8.80% | 4.30% | 0.58% | 7.32% |
| Torrent Pharma. | 2.09% | 1.65% | -0.44% | 6.22% | 17.44% | 25.97% |
| Dr Reddy's Labs | 1.43% | 9.33% | 6.38% | 9.02% | 3.43% | 11.25% |
| Lupin | 1.00% | 0.31% | 0.27% | 9.30% | 20.71% | 10.03% |
| Zydus Lifesci. | 2.43% | 2.24% | 9.00% | 5.92% | -5.16% | 7.20% |
| Mankind Pharma | 0.49% | 3.75% | 13.57% | 7.68% | -5.27% | -10.99% |
Company Info
Company Information
Chairman (Non-Executive) : Y K Hamied
Non Executive Director : Adil Zainulbhai
Managing Director & Global CEO : Umang Vohra
Company Sec. & Compli. Officer : Rajendra Chopra
Independent Director : Robert A Stewart
Vice Chairman : P R Ramesh
Independent Director : Mandar Purushottam Vaidya
Non Executive Director : Abhijit A Joshi
Non Executive Director : Kamil Hamied
Independent Director : Sharmila Paranjpe
Independent Director : Maya Hari
Independent Director : Dr Balram Bhargava